Skip Navigation


Brain Advance Access originally published online on June 5, 2009
Brain 2009 132(10):e125; doi:10.1093/brain/awp161
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
132/10/e125    most recent
awp161v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Gan-Or, Z.
Right arrow Articles by Orr-Urtreger, A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gan-Or, Z.
Right arrow Articles by Orr-Urtreger, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author (2009). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Differential phenotype in Parkinson's disease patients with severe versus mild GBA mutations

Z. Gan-Or1,2, N. Giladi2,3 and A. Orr-Urtreger1,2

1 The Genetic Institute, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel 2 The Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel 3 Movement Disorders Unit Parkinson Center, Department of Neurology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel

Correspondence to: Avi Orr-Urtreger, Genetic Institute, Tel Aviv Sourasky Medical Center, 6 Weizmann Street, Tel Aviv 64239, Israel E-mail: aviorr@tasmc.health.gov.il

Received March 23, 2009. Revised April 21, 2009. Accepted May 14, 2009.

The first 10% of the full text of this article appears below.

Sir, We read with much interest the comprehensive study by Neumann et al. (2009Go), published in Brain, which further demonstrated the importance of GBA mutations as risk factors for Parkinson's disease. GBA mutations are being divided into two groups according to the . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?